3.76
-0.08 (-2.08%)
-0.08 (-2.08%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 56,616 |
|
|||||
| News | - | ||||||
| Day High | 3.98 | Low High |
|||||
| Day Low | 3.7646 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cyclo Therapeutics Inc | CYTH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.08 | -2.08% | 3.76 | 18:57:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.85 | 3.7646 | 3.98 | 3.82 | 3.84 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 399 | 56,616 | $ 3.84 | $ 217,641 | - | 3.43 - 17.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:57:04 | formt | 100 | $ 3.76 | USD |
Period:
Draw Mode:
Cyclo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 31.60M | 8.41M | 7.77M | $ 903.38k | $ - | -6.47 | -1.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 46.65k | - |
Cyclo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYTH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.50 | 4.50 | 3.7646 | 4.09 | 87,051 | -0.74 | -16.44% |
| 1 Month | 3.90 | 5.12 | 3.43 | 4.18 | 124,386 | -0.14 | -3.59% |
| 3 Months | 5.84 | 8.30 | 3.43 | 5.50 | 186,149 | -2.08 | -35.62% |
| 6 Months | 8.40 | 9.48 | 3.43 | 5.95 | 109,600 | -4.64 | -55.24% |
| 1 Year | 5.86 | 17.75 | 3.43 | 9.55 | 334,841 | -2.10 | -35.84% |
| 3 Years | 4.19 | 17.75 | 3.43 | 7.72 | 534,125 | -0.43 | -10.26% |
| 5 Years | 4.19 | 17.75 | 3.43 | 7.72 | 534,125 | -0.43 | -10.26% |
Cyclo Therapeutics Description
| Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex. |